Phenotypic modifications in Staphylococcus aureus cells exposed to high concentrations of vancomycin and teicoplanin

Frontiers in Microbiology

Volumn 7, Issue JAN, 2016, Pages

  Gonçalves, Fábio D A ^a   de Carvalho, Carla C C R ^a  

^a INSTITUTO SUPERIOR TÉCNICO   (Portugal)

Author keywords

Persistent infection; Staphylococcus aureus; Stress response; Teicoplanin; Vancomycin; Viable but non culturable cells

Indexed keywords

ALPHA GALACTOSIDASE; BACTERIAL ENZYME; BETA GALACTOSIDASE; FATTY ACID; PHOSPHOLIPID; TEICOPLANIN; VANCOMYCIN;

ARTICLE; BACTERIAL CELL; BACTERIAL GROWTH; BACTERIAL METABOLISM; BACTERIAL STRAIN; BACTERIUM CULTURE; CELL MEMBRANE FLUIDITY; CELL MEMBRANE POTENTIAL; CELL POPULATION; CELL VIABILITY; COLONY FORMING UNIT; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; ENZYME ACTIVITY; FATTY ACID ANALYSIS; FLUORESCENCE MICROSCOPY; LIPID ANALYSIS; MICROBIOLOGICAL PARAMETERS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; STAPHYLOCOCCUS AUREUS; TIME DEPENDENT KILLING; ZETA POTENTIAL;

EID: 84957955663     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2016.00013     Document Type: Article

References (69)

1. Allison, K. R., Brynildsen, M. P., and Collins, J. J. (2011a). Heterogeneous bacterial persisters and engineering approaches to eliminate them. Curr. Opin. Microbiol. 14, 593-598. doi: 10.1016/j.mib.2011.09.002.
2. Allison, K. R., Brynildsen, M. P., and Collins, J. J. (2011b). Metabolite-enabled eradication of bacterial persisters by aminoglycosides. Nature 473, 216-220. doi: 10.1038/nature10069.
3. Ayrapetyan, M., Williams, T. C., Baxter, R., and Oliver, J. D. (2015a). Viable but nonculturable and persister cells coexist stochastically and are induced by human serum. Infect. Immun. 83, 4194-4203. doi: 10.1128/IAI.00404-15.
4. Ayrapetyan, M., Williams, T. C., and Oliver, J. D. (2015b). Bridging the gap between viable but non-culturable and antibiotic persistent bacteria. Trends Microbiol. 23, 7-13. doi: 10.1016/j.tim.2014.09.004.
5. Balaban, N. Q., Merrin, J., Chait, R., Kowalik, L., and Leibler, S. (2004). Bacterial persistence as a phenotypic switch. Science 305, 1622-1625. doi: 10.1126/science.1099390.
6. Bascomb, S., and Manafi, M. (1998). Use of enzyme tests in characterization and identification of aerobic and facultatively anaerobic Gram-positive cocci. Clin. Microbiol. Rev. 11, 318-340.
7. Beauregard, D. A., Williams, D. H., Gwynn, M. N., and Knowles, D. J. (1995). Dimerization and membrane anchors in extracellular targeting of vancomycin group antibiotics. Antimicrob. Agents Chemother. 39, 781-785. doi: 10.1128/AAC.39.3.781.
8. Bigger, J. W. (1944). Treatment of staphylococcal infections with penicillin by intermittent sterilisation. Lancet 2, 497-500. doi: 10.1016/S0140-6736(00)74210-3.
9. Bonduriansky, R., Crean, A. J., and Day, T. (2012). The implications of nongenetic inheritance for evolution in changing environments. Evol. Appl. 5, 192-201. doi: 10.1111/j.1752-4571.2011.00213.x.
10. Cafiso, V., Bertuccio, T., Spina, D., Purrello, S., Campanile, F., Di Pietro, C., et al. (2012). Modulating activity of vancomycin and daptomycin on the expression of autolysis cell-wall turnover and membrane charge genes in hVISA and VISA strains. PLoS ONE 7:e29573. doi: 10.1371/journal.pone.0029573.
11. Cañas-Duarte, S. J., Restrepo, S., and Pedraza, J. M. (2014). Novel protocol for persister cells isolation. PLoS ONE 9:e88660. doi: 10.1371/journal.pone.0088660.
12. CLSI (2014). Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Fourth Informational Supplement. CLSI Document M100-S24. Wayne, PA: Clinical and Laboratory Standards Institute.
13. Costerton, J. W., Stewart, P. S., and Greenberg, E. P. (1999). Bacterial biofilms: a common cause of persistent infections. Science 284, 1318-1322. doi: 10.1126/science.284.5418.1318.
14. Cui, L., Isii, T., Fukuda, M., Ochiai, T., Neoh, H.-M., Camargo, I. L. B. D. C., et al. (2010). An RpoB mutation confers dual heteroresistance to daptomycin and vancomycin in Staphylococcus aureus. Antimicrob. Agents Chemother. 54, 5222-5233. doi: 10.1128/AAC.00437-10.
15. Darley, E. S. R., and MacGowan, A. P. (2004). The use and therapeutic drug monitoring of teicoplanin in the UK. Clin. Microbiol. Infect. 10, 62-69. doi: 10.1111/j.1469-0691.2004.00747.x.
16. Dawson, C. C., Intapa, C., and Jabra-Rizk, M. A. (2011). "Persisters": survival at the cellular level. PLoS Pathog. 7:e1002121. doi: 10.1371/journal.ppat.1002121.
17. Day, A. P., and Oliver, J. D. (2004). Changes in membrane fatty acid composition during entry of Vibrio vulnificus into the viable but nonculturable state. J. Microbiol. 42, 69-73.
18. de Carvalho, C. C. C. R. (2012). Adaptation of Rhodococcus erythropolis cells for growth and bioremediation under extreme conditions. Res. Microbiol. 163, 125-136. doi: 10.1016/j.resmic.2011.11.003.
19. de Carvalho, C. C. C. R., Pons, M. N., and da Fonseca, M. M. R. (2003). Principal components analysis as a tool to summarise biotransformation data: influence on cells of solvent type and phase ratio. Biocatal. Biotrans. 21, 305-314. doi: 10.1080/10242420310001630146.
20. de Carvalho, C. C. C. R., Wick, L., and Heipieper, H. J. (2009). Cell wall adaptations of planktonic and biofilm Rhodococcus erythropolis cells to growth on C5 to C16 n-alkane hydrocarbons. Appl. Microbiol. Biotechnol. 82, 311-320. doi: 10.1007/s00253-008-1809-3.
21. de Groote, V. N., Verstraeten, N., Fauvart, M., Kint, C. I., Verbeeck, A. M., Beullens, S., et al. (2009). Novel persistence genes in Pseudomonas aeruginosa identified by high-throughput screening. FEMS Microbiol. Lett. 297, 73-79. doi: 10.1111/j.1574-6968.2009.01657.x.
22. Dhar, N., and McKinney, J. D. (2007). Microbial phenotypic heterogeneity and antibiotic tolerance. Curr. Opin. Microbiol. 10, 30-38. doi: 10.1016/j.mib.2006.12.007.
23. Gefen, O., and Balaban, N. Q. (2009). The importance of being persistent: heterogeneity of bacterial populations under antibiotic stress. FEMS Microbiol. Rev. 33, 704-717. doi: 10.1111/j.1574-6976.2008.00156.x.
24. Goss, C. H., and Muhlebach, M. S. (2011). Review: Staphylococcus aureus and MRSA in cystic fibrosis. J. Cyst. Fibros 10, 298-306. doi: 10.1016/j.jcf.2011.06.002.
25. Grant, S. S., and Hung, D. T. (2013). Persistent bacterial infections, antibiotic tolerance, and the oxidative stress response. Virulence 4, 273-283. doi: 10.4161/viru.23987.
26. Gupta, A., Biyani, M., and Khaira, A. (2011). Vancomycin nephrotoxicity: myths and facts. Neth. J. Med. 69, 379-383.
27. Hansen, S., Lewis, K., and Vulic, M. (2008). Role of global regulators and nucleotide metabolism in antibiotic tolerance in Escherichia coli. Antimicrob. Agents Chemother. 52, 2718-2726. doi: 10.1128/AAC.00144-08.
28. Heipieper, H. J., and Debont, J. A. M. (1994). Adaptation of Pseudomonas putida S12 to ethanol and toluene at the level of fatty acid composition of membranes. Appl. Environ. Microbiol. 60, 4440-4444.
29. Hofsteenge, N., Van Nimwegen, E., and Silander, O. K. (2013). Quantitative analysis of persister fractions suggests different mechanisms of formation among environmental isolates of E. coli. BMC Microbiol. 13:25. doi: 10.1186/1471-2180-13-25.
30. Hsu, C.-Y., Lin, M.-H., Chen, C.-C., Chien, S.-C., Cheng, Y.-H., Su, I. N., et al. (2011). Vancomycin promotes the bacterial autolysis, release of extracellular DNA, and biofilm formation in vancomycin-non-susceptible Staphylococcus aureus. FEMS Immunol. Med. Microbiol. 63, 236-247. doi: 10.1111/j.1574-695X.2011.00846.x.
31. Jablonka, E., Oborny, B., Molnar, I., Kisdi, E., Hofbauer, J., and Czaran, T. (1995). The adaptive advantage of phenotypic memory in changing environments. Philos. T. Roy. Soc. B. 350, 133-141. doi: 10.2307/56329.
32. Johnson, A. P., Uttley, A. H., Woodford, N., and George, R. C. (1990). Resistance to vancomycin and teicoplanin: an emerging clinical problem. Clin. Microbiol. Rev. 3, 280-291.
33. Johnson, P. J. T., and Levin, B. R. (2013). Pharmacodynamics, population dynamics, and the evolution of persistence in Staphylococcus aureus. PLoS Genet. 9:e1003123. doi: 10.1371/journal.pgen.1003123.
34. Jones, T., Yeaman, M. R., Sakoulas, G., Yang, S.-J., Proctor, R. A., Sahl, H.-G., et al. (2008). Failures in clinical treatment of Staphylococcus aureus infection with daptomycin are associated with alterations in surface charge, membrane phospholipid asymmetry, and drug binding. Antimicrob. Agents Chemother. 52, 269-278. doi: 10.1128/AAC.00719-07.
35. Joyce, G. H., Hammond, R. K., and White, D. C. (1970). Changes in membrane lipid composition in exponentially growing Staphylococcus aureus during the shift from 37 to 25 C. J. Bacteriol. 104, 323-330.
36. Keren, I., Shah, D., Spoering, A., Kaldalu, N., and Lewis, K. (2004). Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli. J. Bacteriol. 186, 8172-8180. doi: 10.1128/jb.18624.8172-8180.2004.
37. Lechner, S., Lewis, K., and Bertram, R. (2012). Staphylococcus aureus persisters tolerant to bactericidal antibiotics. J. Mol. Microbiol. Biotechnol. 22, 235-244. doi: 10.1159/000342449.
38. Lewis, K. (2001). Riddle of biofilm resistance. Antimicrob. Agents Chemother. 45, 999-1007. doi: 10.1128/aac.45.4.999-1007.2001.
39. Lewis, K. (2007). Persister cells, dormancy and infectious disease. Nat. Rev. Microbiol. 5, 48-56. doi: 10.1038/nrmicro1557.
40. Lewis, K. (2010). Persister cells. Annu. Rev. Microbiol. 64, 357-372. doi: 10.1146/annurev.micro.112408.134306.
41. Li, L., Mendis, N., Trigui, H., Oliver, J. D., and Faucher, S. P. (2014). The importance of the viable but non-culturable state in human bacterial pathogens. Front. Microbiol. 5:258. doi: 10.3389/fmicb.2014.00258.
42. Marques, M. P. C., Walshe, K., Doyle, S., Fernandes, P., and de Carvalho, C. C. C. R. (2012). Anchoring high-throughput screening methods to scale-up bioproduction of siderophores. Process Biochem. 47, 416-421. doi: 10.1016/j.procbio.2011.11.020.
43. Mirani, Z. A., and Jamil, N. (2013). Effect of vancomycin on the cytoplasmic membrane fatty acid profile of vancomycin-resistant and-susceptible isolates of Staphylococcus aureus. J. Infect. Chemother. 19, 24-33. doi: 10.1007/s10156-012-0447-y.
44. Mishra, N. N., Bayer, A. S., Weidenmaier, C., Grau, T., Wanner, S., Stefani, S., et al. (2014). Phenotypic and genotypic characterization of daptomycin-resistant methicillin-resistant Staphylococcus aureus strains: relative roles of mprF and dlt operons. PLoS ONE 9:e107426. doi: 10.1371/journal.pone.0107426.
45. Nawrocki, K., Crispell, E., and Mcbride, S. (2014). Antimicrobial peptide resistance mechanisms of Gram-positive bacteria. Antibiotics 3, 461. doi: 10.3390/antibiotics3040461.
46. Nieto, M., and Perkins, H. R. (1971). Modifications of the acyl-d-alanyl-d-alanine terminus affecting complex-formation with vancomycin. Biochem. J. 123, 789-803. doi: 10.1042/bj1230789.
47. Oliver, J. D. (2005). The viable but nonculturable state in bacteria. J. Microbiol. 43, 93-100.
48. Orman, M. A., and Brynildsen, M. P. (2013a). Dormancy is not necessary or sufficient for bacterial persistence. Antimicrob. Agents Chemother. 57, 3230-3239. doi: 10.1128/AAC.00243-13.
49. Orman, M. A., and Brynildsen, M. P. (2013b). Establishment of a method to rapidly assay bacterial persister metabolism. Antimicrob. Agents Chemother. 57, 4398-4409. doi: 10.1128/AAC.00372-13.
50. Paenke, I., Sendhoff, B., Rowe, J., and Fernando, C. (2007). "On the adaptive disadvantage of Lamarckianism in rapidly changing environments," in Proceedings of the 9th European conference on Advances in Artificial Life, (Lisbon, Portugal: Springer-Verlag).
51. Parenti, F. (1986). Structure and mechanism of action of teicoplanin. J. Hosp. Infect. 7, 79-83. doi: 10.1016/0195-6701(86)90011-3.
52. Patra, P., and Klumpp, S. (2013). Population dynamics of bacterial persistence. PLoS ONE 8:e62814. doi: 10.1371/journal.pone.0062814.
53. Pinchuk, L. M., Degteva, G. K., and Samoilova, L. N. (1983). Characteristics of the composition of higher fatty acids in methicillin-resistant and methicillin-sensitive Staphylococci. Antibiotiki 28, 412-417.
54. Porter, J., Edwards, C., and Pickup, R. W. (1995). Rapid assessment of physiological status in Escherichia coli using fluorescent probes. J. Appl. Bacteriol. 79, 399-408. doi: 10.1111/j.1365-2672.1995.tb03154.x.
55. Prax, M., and Bertram, R. (2014). Metabolic aspects of bacterial persisters. Front. Cell. Infect. Microbiol. 4:148. doi: 10.3389/fcimb.2014.00148.
56. Rainey, P., Beaumont, H., Ferguson, G., Gallie, J., Kost, C., Libby, E., et al. (2011). The evolutionary emergence of stochastic phenotype switching in bacteria. Microb. Cell Fact. 10:S14. doi: 10.1186/1475-2859-10-S1-S14.
57. Ramamurthy, T., Ghosh, A., Pazhani, G. P., and Shinoda, S. (2014). Current perspectives on viable but non-culturable (VBNC) pathogenic bacteria. Front. Public Health 2:103. doi: 10.3389/fpubh.2014.00103.
58. Reynolds, P. E. (1989). Structure, biochemistry and mechanism of action of glycopeptide antibiotics. Eur. J. Clin. Microbiol. Infect. Dis. 8, 943-950. doi: 10.1007/bf01967563.
59. Rybak, M. J., Lomaestro, B. M., Rotscahfer, J. C., Moellering, R. C., Craig, W. A., Billeter, M., et al. (2009). Vancomycin therapeutic guidelines: a summary of consensus recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists. Clin. Infect. Dis. 49, 325-327. doi: 10.1086/600877.
60. Sinensky, M. (1974). Homeoviscous Adaptation-a homeostatic process that regulates the viscosity of membrane lipids in Escherichia coli. Proc. Natl. Acad. Sci. U.S.A. 71, 522-525. doi: 10.1073/pnas.71.2.522.
61. Singh, R., Ray, P., Das, A., and Sharma, M. (2009). Role of persisters and small-colony variants in antibiotic resistance of planktonic and biofilm-associated Staphylococcus aureus: an in vitro study. J. Med. Microbiol. 58, 1067-1073. doi: 10.1099/jmm.0.009720-0.
62. Singh, V. K., Hattangady, D. S., Giotis, E. S., Singh, A. K., Chamberlain, N. R., Stuart, M. K., et al. (2008). Insertional inactivation of branched-chain a-keto acid dehydrogenase in Staphylococcus aureus leads to decreased branched-chain membrane fatty acid content and increased susceptibility to certain stresses. Appl. Environ. Microbiol. 74, 5882-5890. doi: 10.1128/AEM.00882-08.
63. Stein, G. E., and Wells, E. M. (2010). The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid. Curr. Med. Res. Opin. 26, 571-588. doi: 10.1185/03007990903512057.
64. Wakamoto, Y., Dhar, N., Chait, R., Schneider, K., Signorino-Gelo, F., Leibler, S., et al. (2013). Dynamic persistence of antibiotic-stressed mycobacteria. Science 339, 91-95. doi: 10.1126/science.1229858.
65. Westwell, M. S., Gerhard, U., and Williams, D. H. (1995). Two Conformers of the glycopeptide antibiotic teicoplanin with distinct ligand binding sites. J. Antibiot. 48, 1292-1298. doi: 10.7164/antibiotics.48.1292.
66. White, D. C., and Frerman, F. E. (1968). Fatty acid composition of the complex lipids of Staphylococcus aureus during the formation of the membrane-bound electron transport system. J. Bacteriol. 95, 2198-2209.
67. Xia, J., Sinelnikov, I. V., Han, B., and Wishart, D. S. (2015). MetaboAnalyst 3.0-making metabolomics more meaningful. Nucleic Acids Res. 43, W251-W257. doi: 10.1093/nar/gkv380.
68. Xu, H.-S., Roberts, N., Singleton, F. L., Attwell, R. W., Grimes, D. J., and Colwell, R. R. (1982). Survival and viability of nonculturable Escherichia coli and Vibrio cholerae in the estuarine and marine environment. Microb. Ecol. 8, 313-323. doi: 10.2307/4250723.
69. Zhang, Y.-M., and Rock, C. O. (2008). Membrane lipid homeostasis in bacteria. Nat. Rev. Microbiol. 6, 222-233. doi: 10.1038/nrmicro1839.